Drug recall
Apheresis PF24 Plasma
FDA recall event 93761 · Class II · OneBlood, Inc.
Key facts
| Event ID | 93761 |
|---|---|
| Recall numbers | B-0112-2024, B-0113-2024, B-0114-2024, B-0115-2024, B-0116-2024, B-0117-2024, B-0118-2024, B-0119-2024, B-0120-2024, B-0121-2024, B-0122-2024 |
| Recalling firm | OneBlood, Inc. |
| Product type | Biologics |
| Products | Apheresis PF24 Plasma, Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, Apheresis Red Blood Cells, Leukocytes Reduced, Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated, Liquid Plasma and 6 more |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products, for which donor eligibility screening was incomplete, were distributed. |
| Initiation date | Nov 3, 2023 |
| Report date | Feb 14, 2024 |
| Termination date | Feb 8, 2024 |
| City | Orlando |
| State | FL |
| Country | United States |
| FEI number | 1072425 |
At a glance
- 10–99 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: